Cadila Healthcare Ltd - Share Price
CADILAHC
Cadila Healthcare LtdFinancials
Cadila Healthcare LtdNews & Updates
Nifty Pharma under pressure on broad-based selloff; Dr Reddy's extend loss after Q1; Cadila, Cipla d
Jul 28,2021 01:46 PM
The index is in focus after the government announced that the PLI scheme for Pharmaceuticals is estimated to have an export genera
Cadila Healthcare Ltd down for fifth straight session Jul 26,2021
Cadila receives USFDA approval for Ibrutinib tablets Jul 22,2021
EMA grants Orphan Drug Designation to Cadila's Saroglitazar Mg for treating patients with PBC Jul 22,2021
Nifty Pharma stocks trade higher; Torrent Pharma, Alkem Lab, Sun Pharma stocks lead Jul 22,2021
Zydus receives Orpan Drug status for Saroglitazar Mg in Europe Jul 21,2021
Meeting Type
Meeting Date
| Resolution Type | Description Of Resolution | IiAS Recommendation |
|---|
Peer Comparison
| Name | LTP | PE | Mar Cap | NP Qtr | Div. Yld | Sales Qtr | BV |
|---|
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Cadila Healthcare LtdSummary & Reports
Cadila Healthcare Ltd is a well known research-oriented, technology-driven pharmaceutical company focused on the research areas of biotechnology, formulations and Active Pharmaceutical Ingredients. They are an Indian based pharmaceutical company having their presence around the world. They are having their manufacturing facilities at Ahmedabad, Ankleshwar and Vadodara in Gujarat, Ponda in Goa, Raigad in Maharashtra and Solan in Himacha... More
Registered Office
Zydus Corporate Park S No 536,Khoraj Sarkhej-Gandhinagar H/W,Ahmedabad, Gujarat,382481
Tell. : +91-079-26868100
Website : http://www.zyduscadila.com
Email : upen.shah@zyduscadila.com
Registrar Office
5th Floor 506 to 508, Navrangpura, Ahmedabad-380009 INDIA
Tell. : +91-79-26465179
Website : www.linkintime.co.in
Email : ahmedabad@linkintime.co.in
Reports by cadila-healthcare-ltd-share-price
Latest Release by cadila-healthcare-ltd-share-price
Result Express
Cadila Healthcare Ltd's Q2FY19 consolidated net profit declines 17.13% yoy to Rs417.50cr
Jul 29, 2021 08:33 AM
The company’s consolidated revenue stood at Rs2,961.20cr, down 8.09% yoy but up 2.33% qoq.
Shareholding Snapshot
Loading ...
| Jun - 2021 | |
|---|---|
| Promoter | - |
| Foreign | 0.00% |
| Indian | 74.88% |
| Total Promoter | 74.88% |
| Non Promoter | - |
| Institutions | 15.23% |
| Non-Institutions | 9.90% |
| Total Non-Promoter | 25.12% |
| Custodian | 0.00% |
| Total | 100% |
Corporate Action
Purpose
Dividend
Annc. Date
27 May 2021
Effective. Date
28 Jul 2021
Divi. Type
Final
Divi.(%)
350
Divi. Amt.
3.5
Cadila Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting hel... More
Purpose
Board Meeting
Exp. Date
09 Jul 2021
Annc. Date
09 Jul 2021
Re-appointment of Mr. Ganesh N. Nayak as the Executive Director of the Company for a period of three... More
Purpose
EGM
Exp. Date
11 Jun 2021
Annc. Date
18 May 2021
Extra Ordinary General Meeting of the members of the CompanyCadila Healthcare Ltd has informed BSE r... More
Purpose
Board Meeting
Exp. Date
27 May 2021
Annc. Date
21 May 2021
CADILA HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is ... More
